The in vitro activity of cefmetazole versus that of other antimicrobial drugs was 
damycin and metronidazole, and .2 ,ug/ml for penicillin G.
The 374 organisms tested were recent clinical isolates from the Tufts-New England Medical Center or strains referred there from other hospitals. The Time-kill curves were performed for six strains of the B. fragilis group by using a method previously described (5 (3, 10) , as well as those of others (1, 8) . There was no resistance among the anaerobic cocci to cefmetazole, cefoxitin, or metronidazole. There was some resistance to metronidazole found in the aerotolerant cocci. The activity of cefmetazole against Clostridium spp. was better than that of cefoxitin or penicillin but not as good as that of clindamycin, metronidazole, or piperacillin.
Neither cefmetazole nor cefoxitin showed an inoculum effect with the B. fragilis group or other Bacteroides species. Cefmetazole demonstrated a minimal inoculum effect against Clostridium spp., with 2 of 13 strains showing a significant change in the MIC. Both of these strains were susceptible at the lower inoculum densities (0.5 and 2 ,ug/ml) but resistant at the higher-density (32 p.g/ml).
Time-kill curves run on five strains from the B. fragilis group showed a static effect at the MIC of cefmetazole. At 6 h past the introduction of the drug, the viable count of organisms was within one 10-fold dilution of the 0-time count. One strain of B. fragilis was reduced by three 10-fold dilutions at 6 h. Thus, cefmetazole was bactericidal for this organism. When the concentration of cefmetazole was increased to four times the MIC, four of the six strains showed a cidal effect at 6 h and five of the strains showed a cidal effect at 24 h.
Cefmetazole showed good in vitro activity against Bacteroides spp., Clostridium spp., and anaerobic grampositive cocci, but it was not as effective as other drugs against the B. fragilis group.
